Abstract
A series of new 2-{3-{4-[(5-aryl-1,2,4-oxadiazol-3-yl)methoxy]phenyl}isoxazol-5-yl}-N-(3,4,5-tri-methylphenyl)thiazol-4-amine derivatives is synthesized, and the structures of products are confirmed by 1H and 13C NMR, and mass spectra. The new compounds are tested for their anticancer activity against human cancer cell lines: MCF-7 (breast), A549 (lung), Du-145 (prostate), and MDA MB-231 (breast) by using MTT assay and etoposide as a standard reference. All compounds demonstrate good to moderate activity on all cell lines.
Similar content being viewed by others
References
Mayhoub, A.S., Khaliq, M., and Botting, C., Bioorg. Med. Chem., 2011, vol. 19, p. 3845. doi https://doi.org/10.1016/j.bmc.2011.04.041
Jalilian, A.R., Sattari, S., Bineshmarvasti, M., Shafiee, A., and Daneshtalab, M., Arch. Pharm. Med. Chem., 2000, vol. 333, p. 347.doi https://doi.org/10.1002/1521-4184(200010)333:10%3C347::AID-ARDP347%3E3.0.CO;2-6
Liu, C.L., Li, L., and Li, Z.M., Bioorg. Med. Chem., 2004, vol. 12, p. 2825. doi https://doi.org/10.1016/j.bmc.2004.03.050
Hutchinson, I., Chua, M.S., Browne, H.L., Trapani, V., Bradshaw, T.D., Westwell, A. D., and Stevens, M.F.G., J. Med. Chem., 2001, vol. 44, p. 1446. doi https://doi.org/10.1021/jm001104n
Dawood, K.M., Gawad, H.A., Rageb, E.A., Ellithey, M., and Mohamed, H.A., Bioorg. Med. Chem., 2006, vol. 14, p. 3672. doi https://doi.org/10.1016/j.bmc.2006.01.033
Vicini, P., Geronikaki, A., Anastasia, K., Incerti, M., and Zani, F., Bioorg. Med. Chem., 2006, vol. 14, p. 3859. doi https://doi.org/10.1016/j.bmc.2006.01.043
Kumar, A., Rajput, C.S., and Bhati, S.K., Bioorg. Med. Chem., 2007, vol. 15, p. 3089. doi https://doi.org/10.1016/j.bmc.2007.01.042
Shiradkar, M.R., Murahari, K.K., Gangadasu, H.R., Suresh, T., Kalyan, C.A., Panchal, D., Kaur, R., Burange, P., Ghogare, J., Mokalec, V., and Raut, M., Bioorg. Med. Chem., 2007, vol. 15, p. 3997. doi https://doi.org/10.1016/j.bmc.2007.04.003
Cohen, A., Verhaeghe, P., Crozet, M.D., Hutter, S., Rathelot, P., Vanelle, P., and Azas, N., Eur. J. Med. Chem., 2012, vol. 55, p. 315.doi https://doi.org/10.1016/j.ejmech.2012.07.034
Shih, M.H., and Ying, K.F., Bioorg. Med. Chem., 2004, vol. 12, p. 4633.doi https://doi.org/10.1016/j.bmc.2004.06.033
Abruzzese, E., Breccia, M., and Latagliata, R., Bio. Drugs, 2014, vol. 28, p. 17. doi https://doi.org/10.1007/s40259-013-0056-z
Pace, A., and Pierro, P., Org. Biomol. Chem., 2009, vol. 7, p. 4337. doi https://doi.org/10.1039/B908937C
Pace A., Buscemi, S., and Vivona, N., Org. Prep. Proced. Int., 2005, vol. 37, p. 447. doi https://doi.org/10.1080/00304940509354978
Zhang, H.Z., Kasibhatla, S., and Kuemmerle, J., J. Med. Chem., 2005, vol. 48, p. 5215. doi https://doi.org/10.1021/jm050292k
Axel, K. and Jürgen, E., Pharmaceutical Substances: Syntheses, Patents, Applications, Thieme Chemistry, Stuttgart, Germany, 2001.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yakantham, T., Sreenivasulu, R. & Raju, R.R. Design, Synthesis, and Anticancer Evaluation of 2-{3-{4-[(5-Aryl-1,2,4-oxadiazol-3-yl)methoxy]phenyl}isoxazol-5-yl}-N-(3,4,5-trimethylphenyl)thiazol-4-amine Derivatives. Russ J Gen Chem 89, 1485–1490 (2019). https://doi.org/10.1134/S1070363219070181
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363219070181